Penn Ventricular Tachycardia (VT) Center

Penn EP is recognized globally as a leading center for research, clinical innovation, and treatment of patients with ventricular arrhythmias

Our program continues to grow and is one of the highest volume centers across the globe with over 4,000 patients treated since 1999. Our faculty frequently receive patient referrals from physicians across the United States and beyond for the most complex of patients, many of which have underwent unsuccessful procedures at other centers.   

This experience has served as the basis for many of the critical insights gained regarding disease pathophysiology and the required strategies necessary to successfully treat patients while simultaneously limiting the risks involved. Penn EP, in conjunction with the Mt. Sinai School of Medicine, hosts the annual International VT Symposium, widely considered the preeminent VT conference. 

​The Penn Ventricular Tachycardia (VT) Center was established January 2018 and will create a new model of multi-disciplinary care for the growing population of complex patients referred to Penn for the management of ventricular arrhythmias. The center will also focuses on continuing to grow global educational efforts related to VT ablation and treatment. Drs. Fermin Garcia, Pasquale Santangeli, and Gregory Supple co-direct the Penn VT Center.